Riboflavin ophthalmic solution regulatory update

FDA issued a complete response letter to Avedro for an NDA for VibeX to treat progressive keratoconus or corneal ectasia following refractive surgery. The company said FDA requested more information, but that none of those areas are related to clinical safety or efficacy data in the NDA. The company did not provide further details. ...